MELANIE RICE: Open Payments
NPI 1932430964 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 12 payments from 8 companies in 2025. Trend: 2023 $110 · 2024 $28 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $136 |
| Pharmacosmos Therapeutics Inc. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $26 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $21 |
Products named: REBLOZYL, COSELA, KISQALI, ZYNLONTA, ULTOMIRIS, SCEMBLIX, KEYTRUDA, EPKINLY.
Industry payments across PA — which companies pay providers there.
